People · Operator

Scott D. Milligan

Named in public records as an officer, director or promoter · active 2011–2013 · Other, Other Health Care

7
Companies
8
Filings
$6.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Cyberknife Cancer Institute of Chicago, LLCOtherSeed$2.6M$47.5M2011
CK Property Development, LLCOtherSeed$1.2M$22.3M2011
Memphis CK Leasing LLCOtherPre-Seed$1.0M$23.1M2012
Accelitech Investments II, LLCOtherPre-Seed$600K$13.9M2011
Accelitech Investments IV, LLCOtherPre-Seed$600K$13.9M2012
Accelitech Investments III, LLCOtherPre-Seed$550K$12.7M2012
South Jersey Ck Leasing LlcOther Health CarePre-Seed$400K$12.3M2013
Operator network

Scott D. Milligan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

KERWIN G. BRANDT · 2 companies · 1 sharedKERWIN G. BRANDTDavid G. Sheffert · 9 companies · 7 sharedDavid G. SheffertKerwin D. Brandt · 6 companies · 6 sharedKerwin D. BrandtCyberknife Cancer Institute of Chicago, LLC · $2.6M raisedCyberknife Cancer Ins…CK Property Development, LLC · $1.2M raisedCK Property Developme…Memphis CK Leasing LLC · $1.0M raisedMemphis CK Leasing LLCAccelitech Investments II, LLC · $0.6M raisedAccelitech Investment…Accelitech Investments IV, LLC · $0.6M raisedAccelitech Investment…Accelitech Investments III, LLC · $0.6M raisedAccelitech Investment…South Jersey Ck Leasing Llc · $0.4M raisedSouth Jersey Ck Leasi…Scott D. MilliganSM
Scott D. Milligan Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Scott D. Milligan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David G. Sheffert79
Kerwin D. Brandt66
KERWIN G. BRANDT12

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.